175 related articles for article (PubMed ID: 27568793)
1. Aberrant expression of MicroRNAs in B-cell lymphomas.
Sole C; Larrea E; Manterola L; Goicoechea I; Armesto M; Arestin M; Caffarel M; Araujo A; Fernandez M; Araiz M; Lawrie C
Microrna; 2016 Aug; ():. PubMed ID: 27568793
[TBL] [Abstract][Full Text] [Related]
2. MicroRNAs in Lymphoma: Regulatory Role and Biomarker Potential.
Fernandez-Mercado M; Manterola L; Lawrie CH
Curr Genomics; 2015 Oct; 16(5):349-58. PubMed ID: 27047255
[TBL] [Abstract][Full Text] [Related]
3. Challenges and opportunities of microRNAs in lymphomas.
De Tullio G; De Fazio V; Sgherza N; Minoia C; Serratì S; Merchionne F; Loseto G; Iacobazzi A; Rana A; Petrillo P; Silvestris N; Iacopino P; Guarini A
Molecules; 2014 Sep; 19(9):14723-81. PubMed ID: 25232701
[TBL] [Abstract][Full Text] [Related]
4. [Roles of microRNAs in lymphocytopoiesis and lymphoid malignancies - review].
Zhu MX; Ke XY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Aug; 20(4):1014-9. PubMed ID: 22931675
[TBL] [Abstract][Full Text] [Related]
5. Role of microRNA deregulation in the pathogenesis of diffuse large B-cell lymphoma (DLBCL).
Mazan-Mamczarz K; Gartenhaus RB
Leuk Res; 2013 Nov; 37(11):1420-8. PubMed ID: 24054860
[TBL] [Abstract][Full Text] [Related]
6. MicroRNAs and lymphomagenesis: a functional review.
Lawrie CH
Br J Haematol; 2013 Mar; 160(5):571-81. PubMed ID: 23205669
[TBL] [Abstract][Full Text] [Related]
7. MicroRNAs as Biomarkers of B-cell Lymphoma.
Solé C; Arnaiz E; Lawrie CH
Biomark Insights; 2018; 13():1177271918806840. PubMed ID: 30349178
[TBL] [Abstract][Full Text] [Related]
8. MicroRNAs in B-cell lymphomas: how a complex biology gets more complex.
Musilova K; Mraz M
Leukemia; 2015 May; 29(5):1004-17. PubMed ID: 25541152
[TBL] [Abstract][Full Text] [Related]
9. Non-coding RNAs (miRNAs and lncRNAs) and their roles in lymphogenesis in all types of lymphomas and lymphoid malignancies.
Drillis G; Goulielmaki M; Spandidos DA; Aggelaki S; Zoumpourlis V
Oncol Lett; 2021 May; 21(5):393. PubMed ID: 33777216
[TBL] [Abstract][Full Text] [Related]
10. miRNAs in B-cell lymphoma: Molecular mechanisms and biomarker potential.
Solé C; Larrea E; Di Pinto G; Tellaetxe M; Lawrie CH
Cancer Lett; 2017 Oct; 405():79-89. PubMed ID: 28757417
[TBL] [Abstract][Full Text] [Related]
11. The miR-17-92 microRNA cluster: a novel diagnostic tool in large B-cell malignancies.
Fassina A; Marino F; Siri M; Zambello R; Ventura L; Fassan M; Simonato F; Cappellesso R
Lab Invest; 2012 Nov; 92(11):1574-82. PubMed ID: 22964854
[TBL] [Abstract][Full Text] [Related]
12. Role of microRNAs in B cell leukemias and lymphomas.
Schmidt A; Küppers R
Curr Mol Med; 2014; 14(5):580-97. PubMed ID: 24894178
[TBL] [Abstract][Full Text] [Related]
13. MicroRNAs in lymphoma, from diagnosis to targeted therapy.
Jardin F; Figeac M
Curr Opin Oncol; 2013 Sep; 25(5):480-6. PubMed ID: 23852382
[TBL] [Abstract][Full Text] [Related]
14. Tissue-Specific microRNA Expression Profiling to Derive Novel Biomarkers for the Diagnosis and Subtyping of Small B-Cell Lymphomas.
Hue SS; Jin Y; Cheng H; Bin Masroni MS; Tang LWT; Ho YH; Ong DB; Leong SM; Tan SY
Cancers (Basel); 2023 Jan; 15(2):. PubMed ID: 36672402
[TBL] [Abstract][Full Text] [Related]
15. microRNAs: Key Players in Hematopoiesis.
Raghuwanshi S; Karnati HK; Sarvothaman S; Gutti U; Saladi RG; Tummala PR; Gutti RK
Adv Exp Med Biol; 2015; 887():171-211. PubMed ID: 26662992
[TBL] [Abstract][Full Text] [Related]
16. Predictive and prognostic molecular biomarkers in lymphomas.
Iorgulescu JB; Medeiros LJ; Patel KP
Pathology; 2024 Mar; 56(2):239-258. PubMed ID: 38216400
[TBL] [Abstract][Full Text] [Related]
17. The Multifaceted Role and Utility of MicroRNAs in Indolent B-Cell Non-Hodgkin Lymphomas.
Artemaki PI; Letsos PA; Zoupa IC; Katsaraki K; Karousi P; Papageorgiou SG; Pappa V; Scorilas A; Kontos CK
Biomedicines; 2021 Mar; 9(4):. PubMed ID: 33806113
[TBL] [Abstract][Full Text] [Related]
18. Gastrointestinal B-cell lymphomas: From understanding B-cell physiology to classification and molecular pathology.
Sagaert X; Tousseyn T; Yantiss RK
World J Gastrointest Oncol; 2012 Dec; 4(12):238-49. PubMed ID: 23443141
[TBL] [Abstract][Full Text] [Related]
19. Circulating miRNAs as Biomarkers in Aggressive B Cell Lymphomas.
Drees EEE; Pegtel DM
Trends Cancer; 2020 Nov; 6(11):910-923. PubMed ID: 32660885
[TBL] [Abstract][Full Text] [Related]
20. Serum miR-22 as potential non-invasive predictor of poor clinical outcome in newly diagnosed, uniformly treated patients with diffuse large B-cell lymphoma: an explorative pilot study.
Marchesi F; Regazzo G; Palombi F; Terrenato I; Sacconi A; Spagnuolo M; Donzelli S; Marino M; Ercolani C; Di Benedetto A; Blandino G; Ciliberto G; Mengarelli A; Rizzo MG
J Exp Clin Cancer Res; 2018 May; 37(1):95. PubMed ID: 29716630
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
